Its blockbuster cystic fibrosis treatment costs $300,000 a year. Now Vertex wants to solve the opioid crisis

With revenues having more than doubled since 2019, to $10bn, US pharma group targets painkillers
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news